Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study

Purpose TFE3-rearranged/TFEB-altered renal cell carcinoma (RCC) is a rare subtype of RCC. Due to its rarity, there is an unmet medical need for effective therapies in advanced settings. The study aims to investigate the clinical and histopathological characteristics of patients with microphthalmia t...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park
Materialtyp: Artikel
Språk:English
Publicerad: Korean Urological Oncology Society 2024-03-01
Serie:Journal of Urologic Oncology
Ämnen:
-rearranged
-altered
renal cell carcinoma
tyrosine kinase inhibitors
immune checkpoint inhibitors
Länkar:http://www.e-juo.org/upload/pdf/juo-234600660033.pdf

Internet

http://www.e-juo.org/upload/pdf/juo-234600660033.pdf

Liknande verk